# Statera Biopharma, Inc. (STAB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/STAB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2022 | $ 2.72M | $ -20.32M | $ -5.29M | $ 7.41M | $ -10.24M |
| 2021 | $ 1.77M | $ -121.07M | $ -33.73M | $ 16.26M | $ -1.57M |
| 2020 | $ 0 | $ -13.92M | $ 4.17M | $ 2.00M | $ -3.66M |
| 2019 | $ 0 | $ -2.50M | $ -1.07M | $ 0 | $ 984.3K |
| 2018 | $ 0 | $ -4.20M | $ -1.58M | $ 0 | $ -1.45M |
| 2017 | $ 0 | $ -11.50M | $ -3.12M | $ 0 | $ 2.20M |
| 2016 | $ 0 | $ -1.96M | $ -3.10M | $ 0 | $ 7.52M |
| 2015 | $ 0 | $ -15.75M | $ -3.13M | $ 0 | $ 9.89M |
| 2014 | $ 0 | $ -13.63M | $ -4.00M | $ 0 | $ 15.68B |
| 2013 | $ 0 | $ -24.03M | $ -9.96M | $ 7.21B | $ -9.52B |
| 2012 | $ 0 | $ -30.82M | $ -6.92M | $ 169.28M | $ 6.33B |
| 2011 | $ 0 | $ 8.62M | N/A | $ 0 | $ 0 |
| 2010 | $ 0 | $ -16.00M | N/A | $ 0 | $ -15.70B |
| 2009 | $ 0 | $ -22.14M | N/A | $ 0 | $ 0 |
| 2008 | $ 0 | $ -16.06M | $ -6.17M | $ 0 | $ 538.26M |
| 2007 | $ 486.7K | $ -44.77M | N/A | $ 0 | $ 14.19M |
| 2006 | $ 0 | $ -4.34M | $ -54.4K | $ 0 | $ 5.59M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.72 |
| Liabilities / Eq | -2.24 |
| Current Ratio | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/STAB.md)
- [Charts](https://sponda.capital/en/STAB/charts.md)
- [Compare](https://sponda.capital/en/STAB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.